Sorrento Therapeutics Inc (SRNE)
0.0135
0.00 (0.00%)
USD |
OTCM |
May 10, 15:57
Sorrento Therapeutics Cash from Investing (TTM): -11.58M for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -11.58M |
March 31, 2023 | -13.17M |
December 31, 2022 | -28.52M |
September 30, 2022 | -25.69M |
June 30, 2022 | -12.20M |
March 31, 2022 | 68.19M |
December 31, 2021 | 79.85M |
September 30, 2021 | 70.64M |
June 30, 2021 | 40.02M |
March 31, 2021 | -41.91M |
December 31, 2020 | -39.92M |
September 30, 2020 | -38.90M |
June 30, 2020 | -16.93M |
March 31, 2020 | -15.93M |
December 31, 2019 | -38.17M |
September 30, 2019 | -33.23M |
June 30, 2019 | -42.91M |
March 31, 2019 | -43.02M |
December 31, 2018 | -21.20M |
September 30, 2018 | -17.35M |
June 30, 2018 | -9.001M |
March 31, 2018 | -12.82M |
December 31, 2017 | -16.53M |
September 30, 2017 | -27.34M |
June 30, 2017 | -25.56M |
Date | Value |
---|---|
March 31, 2017 | -21.02M |
December 31, 2016 | -17.45M |
September 30, 2016 | -6.795M |
June 30, 2016 | 22.32M |
March 31, 2016 | 13.80M |
December 31, 2015 | 12.55M |
September 30, 2015 | 4.151M |
June 30, 2015 | -22.39M |
March 31, 2015 | -12.34M |
December 31, 2014 | -10.59M |
September 30, 2014 | -0.192M |
June 30, 2014 | -0.473M |
March 31, 2014 | -0.39M |
December 31, 2013 | -0.503M |
September 30, 2013 | -0.8009M |
June 30, 2013 | -0.4653M |
March 31, 2013 | -0.5295M |
December 31, 2012 | -0.548M |
September 30, 2012 | -0.7322M |
June 30, 2012 | -0.6133M |
March 31, 2012 | -1.141M |
December 31, 2011 | -1.052M |
September 30, 2011 | -0.8106M |
June 30, 2011 | -0.7491M |
March 31, 2011 | -0.1422M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-42.91M
Minimum
Jun 2019
79.85M
Maximum
Dec 2021
-5.904M
Average
-16.93M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Scilex Holding Co | -- |
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |